Pulse Brain · Growing Health Evidence Index
Tier 3 — Observational / field trialPeer-reviewed

Physiological responses during ascent to high altitude and the incidence of acute mountain sickness

Alexandra Cobb, Denny Levett, Kay Mitchell, W Aveling, Daniel Hurlbut, Edward T. Gilbert-Kawai, P. J. Hennis, Monty Mythen, Michael P. W. Grocott, Daniel Martín, Caudwell Xtreme Everest, Xtreme Everest 2009, Xtreme Everest 2 investigators, Vineet Ahuja, Golnar Aref-Adib, Robert Burnham, Alexandra Chisholm, Kieran Clarke, David Coates, Matthew Coates, Derek G. Cook, Mark Cox, S Dhillon, C Dougall, Pat Doyle, Pamela W. Duncan, Mark Edsell, Laura Edwards, Lauren Evans, Peter Gardiner, Michael P. W. Grocott, P Gunning, Nicholas Hart, Jane Harrington, John Julian Harvey, C Holloway, Diantha B. Howard, David Hurlbut, Chris Imray, Can İnce, Jildou van der Kaaij, Maryam Khosravi, Nicky Kolfschoten, D Levett, H Luery, Andrew M. Luks, Daniel Martín, Roger McMorrow, Paula Meale, Kay Mitchell, Hugh Montgomery, Gareth J. Morgan, J Morgan, Andrew J. Murray, M Mythen, Stanton Newman, Michael O’Dwyer, James W. Pate, Timothy Plant, Matiram Pun, Paul Richards, Alan Richardson, George W. Rodway, John B. Simpson, Catherine Stroud, M Stroud, J Stygal, Barbara Symons, Piotr Szawarski, A Van Tulleken, Chris van Tulleken, André Vercueil, Liesl Wandrag, Mark H. Wilson, Jeremy S. Windsor, B Basnyat, Caroline S. Clarke, Thomas F. Hornbein, James S. Milledge, James A. West, Sabu Abraham, Tom Adams, W Anseeuw, Rónan Astin, B Basnyat, Oliver Burdall, Janet T. Carroll, Alistair R.M. Cobb, Jonny Coppel, Orestes Couppis, J. H. Court, Andrew F. Cumpstey, Thomas Davies, S Dhillon, Norman G. Diamond, C Dougall, T Geliot, Edward T. Gilbert-Kawai, Grace Gilbert-Kawai, Erich Gnaiger, Michael P. W. Grocott, C Haldane

Physiological Reports · 2021

Read source ↗ All evidence

Summary

This observational cohort study from the Xtreme Everest expeditions characterised physiological responses during high-altitude ascent and identified predictors of acute mountain sickness. Lower oxygen saturation and absence of prior exposure above 5000 m were significant independent predictors of moderate-to-severe AMS. The authors propose the Xtreme Everest Step-Test as a simple, reproducible field-based screening tool, though acknowledge its modest predictive precision.

UK applicability

These findings on AMS prediction may inform pre-expedition health screening for UK-based mountaineers and high-altitude workers. The proposed step-test could be integrated into occupational health assessments for UK personnel planning high-altitude deployment, though clinical utility in routine UK healthcare settings is limited.

Key measures

Oxygen saturation (SpO₂); previous high-altitude exposure history (≥5000 m); acute mountain sickness incidence (moderate-to-severe); Xtreme Everest Step-Test performance

Outcomes reported

The study characterised physiological responses during high-altitude ascent and identified predictive factors for acute mountain sickness (AMS) development. Oxygen saturation levels and prior altitude exposure history were evaluated as prognostic markers, and a field-based screening test was proposed.

Theme
Nutrition & health
Subject
Other / interdisciplinary
Study type
Research
Study design
Observational cohort
Source type
Peer-reviewed study
Status
Published
Geography
International
System type
Human clinical
DOI
10.14814/phy2.14809
Catalogue ID
BFmovi1x8l-gd6ogx

Topic tags

Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.